Orbimed Advisors as of Dec. 31, 2022
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 115 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Sinovac Biotech (SVA) | 6.5 | $340M | 2.7M | 125.06 | |
UnitedHealth (UNH) | 3.9 | $202M | 381k | 530.18 | |
Bristol Myers Squibb (BMY) | 3.6 | $186M | 2.6M | 71.95 | |
Boston Scientific Corporation (BSX) | 3.5 | $180M | 3.9M | 46.27 | |
Humana (HUM) | 3.4 | $179M | 349k | 512.19 | |
BioMarin Pharmaceutical (BMRN) | 3.2 | $167M | 1.6M | 103.49 | |
Intuitive Surgical Com New (ISRG) | 3.2 | $165M | 621k | 265.35 | |
Springworks Therapeutics (SWTX) | 2.6 | $137M | 5.3M | 26.01 | |
Edgewise Therapeutics (EWTX) | 2.5 | $130M | 15M | 8.94 | |
Sarepta Therapeutics (SRPT) | 2.4 | $126M | 972k | 129.58 | |
Verona Pharma Sponsored Ads (VRNA) | 2.3 | $120M | 4.6M | 26.13 | |
Stryker Corporation (SYK) | 2.3 | $118M | 481k | 244.49 | |
Seagen | 2.3 | $117M | 914k | 128.51 | |
Compass Therapeutics (CMPX) | 2.2 | $113M | 22M | 5.03 | |
Thermo Fisher Scientific (TMO) | 2.1 | $111M | 202k | 550.69 | |
Theseus Pharmaceuticals | 1.6 | $86M | 17M | 4.98 | |
Neurocrine Biosciences (NBIX) | 1.6 | $82M | 688k | 119.44 | |
Keros Therapeutics (KROS) | 1.5 | $81M | 1.7M | 48.02 | |
Evolent Health Cl A (EVH) | 1.5 | $79M | 2.8M | 28.08 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.5 | $78M | 272k | 288.78 | |
Natera (NTRA) | 1.5 | $78M | 1.9M | 40.17 | |
Terns Pharmaceuticals (TERN) | 1.5 | $78M | 7.6M | 10.18 | |
Ionis Pharmaceuticals (IONS) | 1.4 | $75M | 2.0M | 37.77 | |
Silverback Therapeutics (SPRY) | 1.4 | $75M | 8.7M | 8.53 | |
Biogen Idec (BIIB) | 1.4 | $72M | 258k | 276.92 | |
Pfizer (PFE) | 1.4 | $71M | 1.4M | 51.24 | |
Adicet Bio (ACET) | 1.3 | $67M | 7.4M | 8.94 | |
Edwards Lifesciences (EW) | 1.2 | $64M | 861k | 74.61 | |
Vaxcyte (PCVX) | 1.2 | $62M | 1.3M | 47.95 | |
Vectivbio Hldg Ord Shs | 1.2 | $61M | 7.0M | 8.66 | |
Prelude Therapeutics (PRLD) | 1.2 | $61M | 10M | 6.04 | |
Tenet Healthcare Corp Com New (THC) | 1.1 | $60M | 1.2M | 48.79 | |
Crinetics Pharmaceuticals In (CRNX) | 1.1 | $59M | 3.2M | 18.30 | |
Mirati Therapeutics | 1.1 | $58M | 1.3M | 45.31 | |
Pmv Pharmaceuticals (PMVP) | 1.1 | $57M | 6.6M | 8.70 | |
Chinook Therapeutics | 1.0 | $53M | 2.0M | 26.20 | |
Mersana Therapeutics (MRSN) | 1.0 | $53M | 9.0M | 5.86 | |
Syndax Pharmaceuticals (SNDX) | 1.0 | $51M | 2.0M | 25.45 | |
Repare Therapeutics Ord (RPTX) | 0.9 | $49M | 3.3M | 14.71 | |
Xtant Med Hldgs Com New (XTNT) | 0.9 | $48M | 73M | 0.66 | |
89bio (ETNB) | 0.9 | $47M | 3.7M | 12.73 | |
Si-bone (SIBN) | 0.9 | $46M | 3.4M | 13.60 | |
Xenon Pharmaceuticals (XENE) | 0.9 | $45M | 1.1M | 39.43 | |
Aclaris Therapeutics (ACRS) | 0.8 | $43M | 2.8M | 15.75 | |
Disc Medicine (IRON) | 0.8 | $43M | 2.2M | 19.89 | |
Abcellera Biologics (ABCL) | 0.8 | $42M | 4.2M | 10.13 | |
Scpharmaceuticals (SCPH) | 0.8 | $40M | 5.6M | 7.17 | |
Uniqure Nv SHS (QURE) | 0.8 | $40M | 1.7M | 22.67 | |
Bellus Health Com New | 0.7 | $39M | 4.7M | 8.21 | |
Janux Therapeutics (JANX) | 0.7 | $37M | 2.8M | 13.17 | |
Arcutis Biotherapeutics (ARQT) | 0.7 | $36M | 2.5M | 14.80 | |
Tela Bio (TELA) | 0.7 | $35M | 3.0M | 11.50 | |
Alx Oncology Hldgs (ALXO) | 0.6 | $32M | 2.9M | 11.27 | |
Ikena Oncology Nonvoting | 0.6 | $32M | 12M | 2.66 | |
Kezar Life Sciences (KZR) | 0.6 | $32M | 4.6M | 7.04 | |
Progyny (PGNY) | 0.6 | $32M | 1.0M | 31.15 | |
Ventyx Biosciences (VTYX) | 0.6 | $30M | 925k | 32.79 | |
Alpine Immune Sciences | 0.6 | $30M | 4.1M | 7.35 | |
Travere Therapeutics (TVTX) | 0.5 | $26M | 1.3M | 21.03 | |
Third Harmonic Bio (THRD) | 0.5 | $25M | 5.8M | 4.30 | |
Rapt Therapeutics (RAPT) | 0.5 | $25M | 1.3M | 19.80 | |
Kinnate Biopharma | 0.5 | $25M | 4.0M | 6.10 | |
Cincor Pharma | 0.4 | $23M | 1.9M | 12.29 | |
Aerovate Therapeutics (AVTE) | 0.4 | $22M | 760k | 29.30 | |
Horizon Therapeutics Pub L SHS | 0.4 | $20M | 171k | 113.80 | |
Gracell Biotechnologies Sponsored Ads | 0.3 | $18M | 7.9M | 2.30 | |
Imara | 0.3 | $18M | 4.4M | 4.09 | |
Gh Research Ordinary Shares (GHRS) | 0.3 | $16M | 1.6M | 9.72 | |
Rxsight (RXST) | 0.3 | $15M | 1.2M | 12.67 | |
Moderna (MRNA) | 0.3 | $15M | 83k | 179.62 | |
Iovance Biotherapeutics (IOVA) | 0.2 | $13M | 2.0M | 6.39 | |
Bridgebio Pharma Note 2.250% 2/0 (Principal) | 0.2 | $13M | 30M | 0.42 | |
Passage Bio (PASG) | 0.2 | $12M | 8.9M | 1.38 | |
Fusion Pharmaceuticals | 0.2 | $10M | 3.2M | 3.15 | |
Decibel Therapeutics | 0.2 | $10M | 4.9M | 2.05 | |
2seventy Bio Common Stock (TSVT) | 0.2 | $9.8M | 1.0M | 9.37 | |
Oric Pharmaceuticals (ORIC) | 0.2 | $9.5M | 1.6M | 5.89 | |
Chemomab Therapeutics Sponsored Ads (CMMB) | 0.2 | $8.3M | 2.6M | 3.20 | |
Scholar Rock Hldg Corp (SRRK) | 0.2 | $8.0M | 879k | 9.05 | |
Mereo Biopharma Group Spon Ads (MREO) | 0.2 | $8.0M | 11M | 0.75 | |
Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.2 | $8.0M | 20M | 0.40 | |
Adagio Therapeutics (IVVD) | 0.2 | $7.9M | 5.3M | 1.50 | |
Ikena Oncology (IKNA) | 0.1 | $7.8M | 2.9M | 2.66 | |
Cullinan Oncology (CGEM) | 0.1 | $6.7M | 637k | 10.55 | |
Verastem | 0.1 | $6.6M | 17M | 0.40 | |
Spdr Ser Tr S&p Biotech (XBI) | 0.1 | $6.3M | 76k | 83.00 | |
Amicus Therapeutics (FOLD) | 0.1 | $6.3M | 516k | 12.21 | |
Argenx Se Sponsored Adr (ARGX) | 0.1 | $6.1M | 16k | 378.83 | |
Neuropace (NPCE) | 0.1 | $6.0M | 4.0M | 1.49 | |
Corvus Pharmaceuticals (CRVS) | 0.1 | $5.9M | 6.9M | 0.85 | |
X4 Pharmaceuticals (XFOR) | 0.1 | $5.8M | 5.8M | 0.99 | |
Vigil Neuroscience (VIGL) | 0.1 | $5.6M | 449k | 12.50 | |
Biontech Se Sponsored Ads (BNTX) | 0.1 | $5.5M | 36k | 150.22 | |
Sanofi Sponsored Adr Call Option (SNY) | 0.1 | $4.8M | 100k | 48.43 | |
Galecto (GLTO) | 0.1 | $4.7M | 4.1M | 1.15 | |
Synlogic | 0.1 | $4.6M | 6.0M | 0.76 | |
Nextcure (NXTC) | 0.1 | $3.8M | 2.7M | 1.41 | |
Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.1 | $3.2M | 1.6M | 1.99 | |
Acutus Medical (AFIB) | 0.1 | $3.0M | 2.6M | 1.15 | |
Bioatla (BCAB) | 0.1 | $2.7M | 332k | 8.25 | |
Applied Therapeutics (APLT) | 0.0 | $2.3M | 3.1M | 0.76 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $2.2M | 831k | 2.68 | |
Graybug Vision Common | 0.0 | $2.1M | 4.2M | 0.50 | |
Goodrx Hldgs Com Cl A (GDRX) | 0.0 | $1.8M | 388k | 4.66 | |
Eyepoint Pharmaceuticals Com New (EYPT) | 0.0 | $1.7M | 488k | 3.50 | |
Cybin Ord (CYBN) | 0.0 | $1.7M | 5.4M | 0.31 | |
Pyxis Oncology Common Stock (PYXS) | 0.0 | $1.1M | 848k | 1.34 | |
Harpoon Therapeutics | 0.0 | $1.1M | 1.5M | 0.73 | |
Singular Genomics Systems In | 0.0 | $1.1M | 541k | 2.01 | |
Bolt Biotherapeutics (BOLT) | 0.0 | $1.0M | 771k | 1.30 | |
Essa Pharma Com New (EPIX) | 0.0 | $921k | 365k | 2.52 | |
Merrimack Pharmaceuticals In Com New | 0.0 | $844k | 74k | 11.46 | |
Aeglea Biotherapeutics | 0.0 | $809k | 1.8M | 0.45 | |
Chardan Healthcare Acqu- Ord (PHGE) | 0.0 | $525k | 2.8M | 0.19 | |
Monte Rosa Therapeutics (GLUE) | 0.0 | $208k | 27k | 7.61 |